The Intelligent Surgery Blog

At Enhatch, we strongly believe that open, digital ecosystems will deliver a universe of innovation to enhance the future of surgery, not only for orthopaedics but the entire medical device industry.

AI is here to stay, and the Covid-19 pandemic accelerated the adoption of AI in healthcare. Organizations are increasingly using AI to help reduce costs and enhance customer experience, including the world of supply chain. 

During the NASS 2021 meeting, Enhatch interviewed leaders working in top health tech companies about their work and how it impacts the Intelligent Surgery Ecosystem. In this interview Ecosystem Specialist Ashley Porto sat down with Dave Anderson, co-founder of Mach Medical.

Medical device companies are under pressure to do more with less. 

The healthcare system is focused on patient-centricity, which means having to sustain a high quality of service. Additionally, market competition between device companies is fierce, there are more regulations than years prior, and reimbursements continue to drop. 

Medical device companies must meet customer expectations, continue to innovate and stay competitive while lowering costs. Artificial Intelligence (AI) can be the balm to ease some of the burdens on medical device manufacturers. 

• Orthopedic surgery needs a more efficient medical device supply network

• AI for inventory management could be a strategic solution 

• Patient specific implants can reduce the number of parts moving, and artificial intelligence can help automate the design process